NYSE - Delayed Quote • USD
Envista Holdings Corporation (NVST)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:22 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 12 |
| Avg. Estimate | 0.3 | 0.32 | 1.24 | 1.41 |
| Low Estimate | 0.25 | 0.26 | 1.09 | 1.18 |
| High Estimate | 0.35 | 0.36 | 1.35 | 1.61 |
| Year Ago EPS | 0.43 | 0.43 | 1.53 | 1.24 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 12 |
| Avg. Estimate | 651.45M | 636.87M | 2.57B | 2.66B |
| Low Estimate | 635.5M | 620.31M | 2.53B | 2.57B |
| High Estimate | 663.1M | 650.35M | 2.61B | 2.74B |
| Year Ago Sales | 662.4M | 648.64M | 2.57B | 2.57B |
| Sales Growth (year/est) | -1.70% | -1.80% | 0.10% | 3.60% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.41 | 0.46 | 0.34 | 0.31 |
| EPS Actual | 0.43 | 0.43 | 0.29 | 0.26 |
| Difference | 0.02 | -0.03 | -0.05 | -0.05 |
| Surprise % | 4.90% | -6.50% | -14.70% | -16.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.3 | 0.32 | 1.24 | 1.41 |
| 7 Days Ago | 0.3 | 0.32 | 1.24 | 1.41 |
| 30 Days Ago | 0.36 | 0.36 | 1.42 | 1.61 |
| 60 Days Ago | 0.36 | 0.36 | 1.42 | 1.61 |
| 90 Days Ago | 0.36 | 0.35 | 1.41 | 1.61 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 2 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NVST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -30.20% | -- | -- | 8.00% |
| Next Qtr. | -25.60% | -- | -- | 12.40% |
| Current Year | -19.00% | -- | -- | 5.60% |
| Next Year | 13.70% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 6.50% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 5.62% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Goldman Sachs: Sell to Sell | 5/3/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 5/2/2024 |
| Maintains | Baird: Neutral to Neutral | 5/2/2024 |
| Reiterates | Needham: Hold | 5/2/2024 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 4/26/2024 |
| Initiated | Leerink Partners: Underperform | 2/26/2024 |
Related Tickers
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
ICUI ICU Medical, Inc.
103.99
-2.15%
STMN.SW Straumann Holding AG
121.45
-1.70%
BLCO Bausch + Lomb Corporation
14.65
-3.87%
CLPBY Coloplast A/S
12.56
+1.62%
KRMD KORU Medical Systems, Inc.
2.2800
-3.39%
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
ATRC AtriCure, Inc.
23.14
+2.25%
STVN Stevanato Group S.p.A.
20.71
-0.96%
UTMD Utah Medical Products, Inc.
69.72
-1.04%